Description
- Eligibility Criteria:
- 1. Have an HIV-1 infection
- 2. a) Currently take a long-acting injectable therapy for HIV supplied by ViiV as part of a ViiV-sponsored, long-acting injectables therapy trial (LATTE-2, ATLAS-2M, CUSTOMIZE, POLAR, FLAIR, or SOLAR), or
- b) Currently take a long-acting injectable therapy for HIV prescribed by their provider, not in conjunction with a ViiV-sponsored clinical trial, or
- c) No longer taking long-acting injectable therapy for HIV, but previously received three or more injections of long-acting injectable therapy, either:
- * Supplied by ViiV as part of a ViiV-sponsored, long-acting injectables therapy trial (LATTE-2, ATLAS-2M, CUSTOMIZE, POLAR, FLAIR, or SOLAR), or
- * Prescribed by their provider, unrelated to a ViiV-sponsored clinical trial.
- 3. Age 18 or above
- 4. Have no known acute medical problem requiring immediate inpatient treatment
- 5. Able to read and write in English
- 6. Able and willing to provide online informed consent and to complete the online profile
- 7. Not currently enrolled in another clinical trial in which the participant is receiving a long-acting injectable therapy for HIV.
- Participants who meet the eligibility criteria but are still receiving ViiV-supplied drug may enroll in the registry, but will not begin the online questionnaire until they are rolled off of ViiV-supplied long-acting injectable therapy.
Ages Eligible for Study:
18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Yes